Abstract 3321: Real-world clinical outcome analyses in head and neck squamous cell carcinoma (HNSCC) to uncover TIGIT biology in patients treated with first-line immune checkpoint inhibitors
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Gilead Sciences (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409628835
